FSSAI acts against British Life Sciences over infant-food violations in Bengaluru
FSSAI seized misbranded infant food, initiated legal action and destroyed 3.7 metric tonnes of expired stock linked to Bengaluru-based British Life Sciences. The regulator has also proposed front-of-pack red-hexagon warnings for packaged foods high in fat, sugar or salt.
What happened
FSSAI seized misbranded infant food from British Life Sciences in Bengaluru, began legal action and destroyed 3.7 tonnes of expired stock. Separately, it
Key facts
- 3.7 metric tonnes
- Food Safety and Standards Act, 2006
- 2017
Why this matters
Build regulatory diligence around labelling accuracy, quality systems and ageing inventory into FMCG deal screens, with infant nutrition requiring heightened scrutiny.
What to watch
- FSSAI notices, product recalls or license suspensions involving additional infant-nutrition companies.
- Formal notification, final design rules or implementation dates for red-hexagon front-of-pack warnings.
- State-level inspection drives targeting pharmacies, modern trade warehouses, e-commerce sellers or distributors.
- British Life Sciences legal filings, distributor delistings, retailer returns or evidence of broader batch exposure.
- Higher retailer demands for shelf-life thresholds, lab reports, traceability data and supplier penalties.
- Audit expiry controls, batch traceability, label approvals and distributor-held inventory, with infant nutrition prioritized.
- Quarantine and independently test high-risk or slow-moving infant-food stock before regulator inspections force write-offs.
- Build a compliance roadmap for potential front-of-pack nutrient warnings, including SKU-level nutrition mapping and reformulation options.
- Retailers and marketplaces should tighten supplier indemnities, require current FSSAI documentation and improve recall-notification workflows.
- Competitors should prepare trust-led communications around quality assurance, pediatric appropriateness and transparent ingredient disclosure.